Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

Yi Xu, David J. Baylink, Chien Shing Chen, Laren Tan, Jeffrey Xiao, Brandon Park, Ismael Valladares, Mark E. Reeves, Huynh Cao

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1286863
JournalFrontiers in Oncology
Volume13
DOIs
StatePublished - 2023

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • AML
  • BAD
  • Bcl-2
  • CD44
  • JAK/STAT
  • compensation
  • homeostasis
  • tyrosine kinase inhibitor

Cite this